MedReps Career Center: Biotechnology Sales News

Medical leaders are praising last year's passage of the America Invents Act (AIA), saying it will help the industry grow biotechnology jobs while remaining focused on new discoveries and development.Beginning in March 2013, the law, which includes some of the biggest changes to the U.S. patent s...(read more)

Members of the Biotechnology Industry Organization (BIO) are applauding a recent announcement by President Barack Obama to create a new National Bioeconomy Blueprint that will promote medical research and development and boost the creation of more biotechnology jobs.The new 43-page report calls for ...(read more)

Maryland Senator Barbara A. Mikulski continues to tour the state to discuss legislation that affects biotechnology jobs in the region.Mikulski, who is a senior member of the Senate Health, Education Labor and Pensions (HELP) Committee, recently spoke to members of the the biotechnology and pharmaceu...(read more)

It appears that many more biotechnology jobs will be created by companies looking to develop treatments for rare and neglected tropical diseases (NTDs), according to two new reports.For the first time ever, the nonprofit BIO Ventures for Global Health (BVGH) has issued a study on the different types...(read more)

Healthcare leaders are calling on the Food and Drug Administration (FDA) to implement two important user fee initiatives that they say will protect patient safety and help spur innovation for those with biotechnology jobs.Sara Radcliffe, executive vice president of health at the Biotechnology Indust...(read more)

The latest report from industry research firm IBISWorld has found that biotechnology jobs are expected to benefit from healthcare reform, generic drug development and more access to capital investments.According to the report, continued innovation in the the biotechnology industry has helped defend ...(read more)

Looking to boost research and development and spur the creation of more biotechnology jobs, healthcare giants Johnson & Johnson (J&J) and GlaxoSmithKiline have launched a new venture capital fund to help back early-stage biotechnology companies.J&J and GlaxoSmithKline have each pitched i...(read more)

As the healthcare industry praised lawmakers on Capitol Hill for forging ahead with the new Jumpstart Our Business Startups (JOBS) bill, professionals with biotechnology careers are now hoping that additional legislation will help fuel more job growth for smaller biotech companies.The transforming t...(read more)

In a move that could negatively affect the future of biotechnology jobs and industry growth, the Supreme Court has rejected two blood monitoring patent requests by Nestle SA's Prometheus unit.The high court unanimously overturned a lower ruling that allowed the patents for the company's test...(read more)

As humans and machines become increasingly more fused, many patients may be vulnerable to digital viruses, which could affect those with medical device sales jobs and device makers.According to Mass Device, medical device makers are having to take preventative steps to decrease the likelihood of ele...(read more)

Bitotechnology jobs holders will be pleased to hear the U.S. Food and Drug Administration has approved Coviden's EverFlex(TM) Self-Expanding Peripheral Stent System to be used in the superficial femoral artery (SFA) and the proximal popliteal artery (PPA).The system has been approved in markets ...(read more)

Pharmaceutical sales giant Sanofi has partnered with two venture capital firms for a partnership that will invest in future biotechnology jobs with the creation of a new company called Warp Drive Bio to be based in Cambridge, Massachusetts.The French drug maker said the collaboration with Third Rock...(read more)

Although Virginia Governor Bob McDonnell has been able to close 671 business deals since taking office, he said his administration has been lacking when it comes to attracting more biotechnology sales companies to the state. Now, McDonnell has announced he is seeking more than $37 million to fund a ...(read more)

In today's competitive pharmaceutical sales environment, many smaller companies need help as they try to get their product out of the development stage and onto the market. Now, Reata Pharmaceuticals has announced it has entered into an biotechnology sales agreement with Abbott, which will help ...(read more)

Looking to keep up with emerging business trends, Samsung Biologics has announced it is partnering with Massachusetts-based Biogen to expand its biotechnology sales potential of biologic drugs.Biogen said the Korea-based Samsung will help lead in the development, manufacturing and marketing of biosi...(read more)

As more states debate the benefits of medicinal marijuana, one California company is looking to expand its options for the biotechnology sales of compounds from plants.Medical Marijuana Incorporated, the world's first publicly traded medicinal marijuana company, has announced the execution of op...(read more)

Amid the controversy surrounding the use of stem cells in medical procedures, the Food and Drug Administration (FDA) has approved the first blood cord product in the world for biotechnology sales.The federal agency has agreed to licence hemotopoietic progenitor cells-cord, HPC-C, as HEMACORD for ste...(read more)

As pharmaceutical sales companies strive to form bigger, more stable organizations, mergers and acquisitions are becoming an increasingly popular choice. Most recently, Salix Pharmaceuticals and Oceana Therapeutics, LLC have entered into a business agreement.The deal allows Salix to purchase all out...(read more)

Professionals with biotechnology careers understand the impact of collaboration when it comes to advancing a product out of the laboratory and onto the market. Now, Quanticel Pharmaceuticals has announced a strategic partnership with Celgene Corporation and Versant Ventures for the discovery, develo...(read more)

The Biotechnology Industry Organization (BIO) is praising the recent passage by the House of Representatives of the Small Company Capital Formation Act, a bill the group said would help a number of smaller cash-strapped biotechnology sales companies.If approved, the act would reform the current Secu...(read more)